These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 16263811)

  • 1. Identification of a functional polymorphism of the human type 5 17beta-hydroxysteroid dehydrogenase gene associated with polycystic ovary syndrome.
    Qin K; Ehrmann DA; Cox N; Refetoff S; Rosenfield RL
    J Clin Endocrinol Metab; 2006 Jan; 91(1):270-6. PubMed ID: 16263811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of the 17-hydroxysteroid dehydrogenase type 5 gene polymorphism (-71A/G HSD17B5 SNP) with hyperandrogenemia in polycystic ovary syndrome (PCOS).
    Marioli DJ; Saltamavros AD; Vervita V; Koika V; Adonakis G; Decavalas G; Markou KB; Georgopoulos NA
    Fertil Steril; 2009 Aug; 92(2):648-52. PubMed ID: 18692800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonreplication of the type 5 17beta-hydroxysteroid dehydrogenase gene association with polycystic ovary syndrome.
    Goodarzi MO; Jones MR; Antoine HJ; Pall M; Chen YD; Azziz R
    J Clin Endocrinol Metab; 2008 Jan; 93(1):300-3. PubMed ID: 17940109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphisms of the HSD17B6 and HSD17B5 genes in Chinese women with polycystic ovary syndrome.
    Ke L; Che YN; Cao YX; Wu XK; Hu YL; Sun HX; Liang FJ; Sun J; Yi L; Wang Y
    J Womens Health (Larchmt); 2010 Dec; 19(12):2227-32. PubMed ID: 21039282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the basal promoter element of the human type 5 17beta-hydroxysteroid dehydrogenase gene.
    Qin K; Rosenfield RL
    Biochim Biophys Acta; 2005 May; 1728(3):115-25. PubMed ID: 15814298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A study of the hexose-6-phosphate dehydrogenase gene R453Q and 11beta-hydroxysteroid dehydrogenase type 1 gene 83557insA polymorphisms in the polycystic ovary syndrome.
    San Millán JL; Botella-Carretero JI; Alvarez-Blasco F; Luque-Ramírez M; Sancho J; Moghetti P; Escobar-Morreale HF
    J Clin Endocrinol Metab; 2005 Jul; 90(7):4157-62. PubMed ID: 15827106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 17-Hydroxysteroid dehydrogenase type 5 gene polymorphism (-71A/G HSD17B5 SNP) and treatment with oral contraceptive pills in PCOS women without metabolic comorbidities.
    Maier PS; Mattiello SS; Lages L; Spritzer PM
    Gynecol Endocrinol; 2012 Aug; 28(8):606-10. PubMed ID: 22329763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of association between common polymorphisms in the 17beta-hydroxysteroid dehydrogenase type V gene (HSD17B5) and precocious pubarche.
    Petry CJ; Ong KK; Wingate DL; de Zegher F; Ibáñez L; Dunger DB
    J Steroid Biochem Mol Biol; 2007; 105(1-5):176-80. PubMed ID: 17583494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Polymorphism in CYP11alpha and CYP17 genes and the etiology of hyperandrogenism in patients with polycystic ovary syndrome].
    Pérez MS; Cerrone GE; Benencia H; Márquez N; De Piano E; Frechtel GD
    Medicina (B Aires); 2008; 68(2):129-34. PubMed ID: 18499961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association analysis between the polymorphisms of HSD17B5 and HSD17B6 and risk of polycystic ovary syndrome in Chinese population.
    Ju R; Wu W; Fei J; Qin Y; Tang Q; Wu D; Xia Y; Wu J; Wang X
    Eur J Endocrinol; 2015 Mar; 172(3):227-33. PubMed ID: 25422294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of the Pro12Ala polymorphism in peroxisome proliferator-activated receptor gamma2 with decreased basic metabolic rate in women with polycystic ovary syndrome.
    Koika V; Marioli DJ; Saltamavros AD; Vervita V; Koufogiannis KD; Adonakis G; Decavalas G; Georgopoulos NA
    Eur J Endocrinol; 2009 Aug; 161(2):317-22. PubMed ID: 19465486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased frequency of the DI genotype of the angiotensin-I converting enzyme and association of the II genotype with insulin resistance in polycystic ovary syndrome.
    Koika V; Georgopoulos NA; Piouka A; Roupas ND; Karela A; Armeni AK; Katsantoni E; Panidis D
    Eur J Endocrinol; 2012 Apr; 166(4):695-702. PubMed ID: 22223701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Association study between a polymorphism of aldosterone synthetase gene and the pathogenesis of polycystic ovary syndrome].
    Zhao SP; Tang XM; Shao DH; Dai HY; Dai SZ
    Zhonghua Fu Chan Ke Za Zhi; 2003 Feb; 38(2):94-7. PubMed ID: 12783697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic variation in 11beta-hydroxysteroid dehydrogenase type 1 predicts adrenal hyperandrogenism among lean women with polycystic ovary syndrome.
    Gambineri A; Vicennati V; Genghini S; Tomassoni F; Pagotto U; Pasquali R; Walker BR
    J Clin Endocrinol Metab; 2006 Jun; 91(6):2295-302. PubMed ID: 16551740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CAG repeat polymorphism in androgen receptor gene is not directly associated with polycystic ovary syndrome but influences serum testosterone levels.
    Skrgatic L; Baldani DP; Cerne JZ; Ferk P; Gersak K
    J Steroid Biochem Mol Biol; 2012 Feb; 128(3-5):107-12. PubMed ID: 22107839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphism T --> C (-34 base pairs) of gene CYP17 promoter in women with polycystic ovary syndrome is associated with increased body weight and insulin resistance: a preliminary study.
    Echiburú B; Pérez-Bravo F; Maliqueo M; Sánchez F; Crisosto N; Sir-Petermann T
    Metabolism; 2008 Dec; 57(12):1765-71. PubMed ID: 19013303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A functional anti-mullerian hormone gene polymorphism is associated with follicle number and androgen levels in polycystic ovary syndrome patients.
    Kevenaar ME; Laven JS; Fong SL; Uitterlinden AG; de Jong FH; Themmen AP; Visser JA
    J Clin Endocrinol Metab; 2008 Apr; 93(4):1310-6. PubMed ID: 18230658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic variants in peroxisome proliferator-activated receptor gamma influence insulin resistance and testosterone levels in normal women, but not those with polycystic ovary syndrome.
    Antoine HJ; Pall M; Trader BC; Chen YD; Azziz R; Goodarzi MO
    Fertil Steril; 2007 Apr; 87(4):862-9. PubMed ID: 17141766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Correlation between single nucleotide polymorphism of insulin receptor gene with polycystic ovary syndrome].
    Chen ZJ; Shi YH; Zhao YR; Li Y; Tang R; Zhao LX; Chang ZH
    Zhonghua Fu Chan Ke Za Zhi; 2004 Sep; 39(9):582-5. PubMed ID: 15498182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polycystic ovary syndrome susceptibility single nucleotide polymorphisms in women with a single PCOS clinical feature.
    Cui L; Li G; Zhong W; Bian Y; Su S; Sheng Y; Shi Y; Wei D; Zhang W; Zhao H; Chen ZJ
    Hum Reprod; 2015 Mar; 30(3):732-6. PubMed ID: 25586784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.